[go: up one dir, main page]

AR047346A1 - Composicion farmaceutica de vinflunina para administracion parnteral, proceso de preparacion y uso de la misma - Google Patents

Composicion farmaceutica de vinflunina para administracion parnteral, proceso de preparacion y uso de la misma

Info

Publication number
AR047346A1
AR047346A1 ARP040104869A ARP040104869A AR047346A1 AR 047346 A1 AR047346 A1 AR 047346A1 AR P040104869 A ARP040104869 A AR P040104869A AR P040104869 A ARP040104869 A AR P040104869A AR 047346 A1 AR047346 A1 AR 047346A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
administration
vinflunina
parnteral
same
Prior art date
Application number
ARP040104869A
Other languages
English (en)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34630533&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR047346(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR047346A1 publication Critical patent/AR047346A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composicion farmacéutica de vinflunina en forma de una solucion acuosa estable y estéril de una sal de vinflunina de vinflunina soluble en agua, a un pH de entre 3 y 4. Proceso para la preparacion de está composicion y a su uso como una especialidad medicinal para administracion parenteral, en el tratamiento de cancer
ARP040104869A 2003-12-23 2004-12-22 Composicion farmaceutica de vinflunina para administracion parnteral, proceso de preparacion y uso de la misma AR047346A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0315312A FR2863891B1 (fr) 2003-12-23 2003-12-23 Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation

Publications (1)

Publication Number Publication Date
AR047346A1 true AR047346A1 (es) 2006-01-18

Family

ID=34630533

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104869A AR047346A1 (es) 2003-12-23 2004-12-22 Composicion farmaceutica de vinflunina para administracion parnteral, proceso de preparacion y uso de la misma

Country Status (35)

Country Link
US (1) US20070155768A1 (es)
EP (1) EP1696913B1 (es)
JP (2) JP5226220B2 (es)
KR (1) KR101166347B1 (es)
CN (2) CN1897940A (es)
AR (1) AR047346A1 (es)
AT (1) ATE424201T1 (es)
AU (1) AU2004314154B2 (es)
BR (1) BRPI0418005B8 (es)
CA (1) CA2551493C (es)
CR (1) CR8473A (es)
CY (1) CY1109120T1 (es)
DE (1) DE602004019809D1 (es)
DK (1) DK1696913T3 (es)
EC (1) ECSP066663A (es)
ES (1) ES2323374T3 (es)
FR (1) FR2863891B1 (es)
HK (1) HK1089105A1 (es)
IL (1) IL176404A (es)
MA (1) MA28237A1 (es)
MX (1) MXPA06007208A (es)
MY (1) MY139643A (es)
NI (1) NI200600146A (es)
NO (1) NO336427B1 (es)
NZ (1) NZ548028A (es)
OA (1) OA13348A (es)
PL (1) PL1696913T3 (es)
PT (1) PT1696913E (es)
RU (1) RU2362557C2 (es)
SI (1) SI1696913T1 (es)
TN (1) TNSN06197A1 (es)
TW (1) TWI334352B (es)
UA (1) UA83888C2 (es)
WO (1) WO2005070425A1 (es)
ZA (1) ZA200605201B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
CN101129374B (zh) * 2007-06-26 2010-09-08 齐鲁制药有限公司 长春氟宁药物组合物及其制备方法与应用
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
CN101607968A (zh) * 2008-06-17 2009-12-23 江苏豪森药业股份有限公司 长春氟宁盐、其制备方法及其药物组合物
KR101844623B1 (ko) * 2011-03-29 2018-04-02 사노피 안정성이 향상된 오타믹사반 제제
ES2823281T3 (es) 2015-08-01 2021-05-06 Sun Pharmaceutical Ind Ltd Forma de dosificación del fármaco alcaloide vinca
US20190307741A1 (en) * 2016-07-06 2019-10-10 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
CA2001643A1 (en) * 1988-12-23 1990-06-23 Richard L. Wolgemuth Preservative-free multi-dose vincristine solution
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
JPH06100452A (ja) * 1993-04-06 1994-04-12 Asta Medica Ag イホスファミド用の製薬学的容器
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
DE19706255C2 (de) * 1997-02-18 2000-11-30 Schott Glas Sterilisierbarer Glasbehälter für medizinische Zwecke, insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Produkte
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
JP3642492B1 (ja) * 2003-10-31 2005-04-27 小野薬品工業株式会社 オザグレルナトリウム含有水溶液を充填してなる注射用容器
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation

Also Published As

Publication number Publication date
MY139643A (en) 2009-10-30
IL176404A (en) 2010-11-30
NO20063277L (no) 2006-07-14
CN1897940A (zh) 2007-01-17
WO2005070425A1 (fr) 2005-08-04
FR2863891B1 (fr) 2006-03-24
JP5710462B2 (ja) 2015-04-30
JP5226220B2 (ja) 2013-07-03
RU2362557C2 (ru) 2009-07-27
KR20060124624A (ko) 2006-12-05
BRPI0418005A (pt) 2007-04-17
TNSN06197A1 (fr) 2007-11-15
NI200600146A (es) 2006-12-12
PT1696913E (pt) 2009-06-05
JP2007515461A (ja) 2007-06-14
EP1696913B1 (fr) 2009-03-04
ECSP066663A (es) 2006-10-25
FR2863891A1 (fr) 2005-06-24
CA2551493A1 (fr) 2005-08-04
BRPI0418005B1 (pt) 2019-11-26
AU2004314154B2 (en) 2011-03-24
UA83888C2 (ru) 2008-08-26
CA2551493C (fr) 2012-12-04
RU2006126708A (ru) 2008-01-27
MXPA06007208A (es) 2006-08-18
IL176404A0 (en) 2006-10-05
NO336427B1 (no) 2015-08-17
MA28237A1 (fr) 2006-10-02
BRPI0418005B8 (pt) 2021-05-25
CY1109120T1 (el) 2014-07-02
JP2012102120A (ja) 2012-05-31
DE602004019809D1 (de) 2009-04-16
CN101695474A (zh) 2010-04-21
DK1696913T3 (da) 2009-06-29
PL1696913T3 (pl) 2009-08-31
SI1696913T1 (sl) 2009-08-31
NZ548028A (en) 2010-01-29
EP1696913A1 (fr) 2006-09-06
ZA200605201B (en) 2007-09-26
TW200531717A (en) 2005-10-01
CR8473A (es) 2006-11-24
HK1089105A1 (en) 2006-11-24
TWI334352B (en) 2010-12-11
KR101166347B1 (ko) 2012-07-18
OA13348A (fr) 2007-04-13
US20070155768A1 (en) 2007-07-05
ATE424201T1 (de) 2009-03-15
AU2004314154A1 (en) 2005-08-04
ES2323374T3 (es) 2009-07-14

Similar Documents

Publication Publication Date Title
NI200600146A (es) Composición farmacéutica de vinflunina para administración parenteral, proceso de preparación y su uso
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
EP4458896A3 (en) Bioorthogonal compositions
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
AR037629A1 (es) Formulaciones farmaceuticas que comprenden un derivado de platino
CU23367A3 (es) Formulación de moxifloxacino con sal común
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
NO20075136L (no) Nye liposompreparater
UA105210C2 (ru) Противораковая вакцина и ее применение
CO6331425A2 (es) Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
RS52367B (en) GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES
AR047757A1 (es) Aminoacidos n,n-dihalogenados y derivados
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
AR042977A1 (es) Formulaciones farmaceuticas liquidas de palonosetron
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
SE0300098D0 (sv) Use of cyclin D1 inhibitors
BRPI0417350A2 (pt) composiÇço para a distribuiÇço nasal, uso de granisetron ou de um sal farmaceuticamente aceitÁvel do mesmo, e quitosana, um sal, um derivado ou sal de um derivado do mesmo, mÉtodos de administraÇço de granisetron ou de um sal farmaceuticamente aceitÁvel do mesmo, e de tratamento ou prevenÇço de nÁusea e/ou vâmito, e, dispositivo para a distribuiÇço da droga nasal ou um cartucho de dose
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
WO2005041936A3 (en) Methods of treatment of cancer using a composition comprising a cytotoxic drug and a porous carrier material
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
DE602004022783D1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
ATE429435T1 (de) 7h-pyrrolopyrimidinderivate